Condition

Plasma Cell Myeloma Refractory (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Sanofi (1)

Collaborator

Intervention

belantamab mafodotin (1)

dexamethasone (1)

isatuximab sar650984 (1)

pomalidomide (1)

sar439459 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

plasma cell myeloma refractory

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Plasma Cell Myeloma Refractory Trial in Worldwide (Isatuximab SAR650984, Dexamethasone, Pomalidomide)

Recruiting

Plasma Cell Myeloma Refractory

Isatuximab SAR650984
+4 more

Chicago, Illinois
+18 more

Aug 2, 2022